CALCIVIS is an innovative UK dental biologic and device manufacturer focused on revolutionising treatment of tooth decay and enabling preventive dentistry. Headquartered in Edinburgh, Scotland, CALCIVIS brings world-class development and business management expertise to a sector eager to reduce reliance on costly, complex and painful surgical interventions. CALCIVIS is focused on revolutionising the management of dental demineralization by providing what leading clinicians consider to be the “Holy Grail” of cariology (tooth decay): real-time chair side assessment of the caries disease process. Information about activity of enamel demineralization has not been available previously and enables the preventive dentistry approach. By supporting early decision making and improving patient communication, compliance with oral health advice increases and consent for prescribed treatment improves leading to enhanced clinical and professional outcomes.